Joanne Quan, M.D., is a distinguished medical professional serving as the Chief Medical Officer at Mirum Pharmaceuticals Inc. Dr. Quan brings a wealth of experience in the biopharmaceutical industry, having held key leadership positions in several renowned companies. Before joining Mirum, she was the Chief Medical Officer at Ultragenyx Pharmaceutical Inc., where she played a pivotal role in advancing the company's rare disease portfolio. Her expertise in clinical development and regulatory affairs has been instrumental in bringing innovative therapies to patients with unmet medical needs. Dr. Quan's career is marked by significant achievements in the field of medicine and pharmaceuticals. She holds a medical degree from the University of California, San Francisco, and completed her residency in pediatrics at the same institution. Her commitment to improving patient outcomes is evident in her work on various clinical trials and her contributions to the scientific community through numerous publications. Dr. Quan's strategic vision and dedication to patient care have earned her recognition as a thought leader in the industry. In her current role at Mirum Pharmaceuticals Inc., Dr. Joanne Quan oversees the clinical development and medical affairs of the company's pipeline, focusing on treatments for rare liver diseases. Her leadership is crucial in guiding the company's efforts to develop and commercialize novel therapies that address significant medical challenges. Under her guidance, Mirum continues to make strides in bringing transformative treatments to patients, reinforcing its position as a leader in the field of rare disease therapeutics.